Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
phase 3
Biotech
CEPI to fund Moderna's pandemic flu trial after HHS walked away
With support from the U.S. government evaporated, Moderna is leaning on an old ally to carry plans for its prospective mRNA bird flu vaccine forward.
Fraiser Kansteiner
Dec 18, 2025 9:40am
Immunome's desmoid tumor treatment triumphs in phase 3
Dec 15, 2025 10:42am
Arcus halts Gilead-partnered TIGIT trials as it reworks R&D
Dec 12, 2025 10:00am
Capricor sets up 2nd DMD approval attempt with ph. 3 win
Dec 3, 2025 11:11am
Novartis’ phase 3 wins in Sjögren's see high placebo effect
Oct 29, 2025 12:03pm
BridgeBio's calcium deficiency candidate scores phase 3 win
Oct 29, 2025 7:00am
